Colgate-Palmolive Company Q3 2026 Earnings Recap

Colgate-Palmolive’s shares rose 2.3%, a roughly flat reaction, as the company reported growth across most categories and divisions while emphasizing that elevated cost pressures are expected to persist into early 2027. The transcript does not provide the quarter’s full sales or earnings figures or enough detail to assess the specific drivers of gross-margin performance.

Key Takeaways

• Organic sales growth was reported in all four categories and four of five divisions; emerging markets grew mid-single digits, led by India, Brazil, and China.
• Management said base business EPS was ahead of its expectations and free cash flow was up 7%; it also reported $2.2 billion returned to shareholders year to date.
• Hill’s had a “very strong” quarter across therapeutic and wellness, while management said it remains focused on a U.S. turnaround and reported toothpaste market-share improvement.
• The company expects significant cost inflation to remain elevated through the fourth quarter and into early 2027; tariffs are expected to peak in the fourth quarter.
• Management declined to provide 2027 guidance before the first quarter of next year, citing ongoing uncertainty.